Evidence map›Paper›PMID 42147164›Full record

ArticleResearch square2026

DTI-ALPS Is Associated with Temporolimbic Amyloid but Not Plasma p-Tau181 Across the Alzheimer's Disease Continuum.

Rasa Zafari, Amirhossein Kamroo, Tina Taherkhani, Mahsa Heidari-Foroozan, Fardin Nabizdeh, Mohammad Hadi Aarabi

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rasa ZafariTehran University of Medical Sciences.
Amirhossein KamrooTehran University of Medical Sciences.
Tina TaherkhaniTehran University of Medical Sciences.
Mahsa Heidari-ForoozanShahid Beheshti University of Medical Sciences.
Fardin NabizdehIran University of Medical Sciences.
Mohammad Hadi AarabiUniversité de Bordeaux, CNRS, CEA.

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

Background: Alzheimer's disease (AD) is the most common cause of dementia, characterized by progressive aggregation of misfolded proteins. Accumulation of amyloid-beta (Aβ) and hyperphosphorylated tau (p-tau) is the hallmark pathology of AD. Diffusion tensor imaging along the perivascular spaces (DTI-ALPS) has been proposed as an MRI marker related to perivascular diffusivity patterns and has been used in studies of neurodegenerative disease. Aims: This study investigates the association between the association between DTI-ALPS indices, regional amyloid-PET burden, and plasma p-tau181 across the AD spectrum. Methods: Data from 410 individuals was enrolled from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. DTI-ALPS was used as an imaging proxy related to perivascular diffusivity patterns. Results: Mean DTI-ALPS declined progressively from healthy controls to AD. Moreover, females reflected higher DTI-ALPS indices compared with males. No significant associations were observed between perivascular diffusivity patterns and plasma concentration of p-tau 181 in patients with cognitive decline. In contrast, the global cortical amyloid-PET SUVR was associated with the mean [β = -0.163] and right DTI-ALPS indices in the MCI group [β = -0.202]. Moreover, we observed stronger associations between DTI-ALPS index and amyloid-PET SUVR in the temporal pole cortex [β = -0.199], entorhinal cortex [β = -0.224], and parahippocampal gyrus in patients with MCI [β = -0.281]. Conclusions: Reduced DTI-ALPS indices were associated with increased temporolimbic amyloid deposition, particularly in individuals with MCI. These findings suggest DTI-ALPS-derived perivascular diffusivity as an imaging marker associated with amyloid burden in prodromal AD.

Indexed as

Alzheimer’s DiseaseAmyloidDTI-ALPS indexGlymphatic SystemMild Cognitive ImpairmentPerivascular clearance

Identifiers

PMID42147164
PMCPMC13174814

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.